Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Macrophages help activate hair follicle stem cells, affecting hair growth and skin repair.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Pregnancy increases certain GABA_A receptors in rat brains, influenced by steroid levels.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

The skin protects the body and is constantly renewed by stem cells; disruptions can lead to cancer.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

The microenvironment controls adult stem cells' behavior and fate.